← Open Payments lookup

LUZVIMINDA DORSETT: Open Payments

NPI 1508902008 · LONG BRANCH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$712 in 50 payments from 11 companies in 2025. Trend: 2023 $342 · 2024 $649 · 2025 $712

Food & beverage: $712
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation33$291
Incyte Corporation2$140
Janssen Biotech, Inc.3$52
Merck Sharp & Dohme LLC3$48
Cumberland Pharmaceuticals, Inc.1$38
Agios Pharmaceuticals, Inc.2$35
AstraZeneca Pharmaceuticals LP2$33
Eisai Inc.1$20
ABBVIE INC.1$19
Regeneron Healthcare Solutions, Inc.1$19

Products named: KISQALI, Jakafi, KEYTRUDA, SANCUSO, PYRUKYND, RYBREVANT, Lenvima, ELAHERE.

Industry payments across NJ — which companies pay providers there.